As Maidstone and Tunbridge Wells NHS Trust, is part of the South East Genomic Laboratory Hub, could you please answer the following three questions about biomarker testing that the Trust conducts as part of the NHS England Genomic Laboratory Hubs.
Q1. How many patients has the Trust tested for the following Non-Small Cell Lung Cancer biomarkers in the last 6 months?
a. MET (Test Code M4.3)
b. ALK (Test Code M4.11)
c. ROS1 (Test Code M4.6)
d. EGFR (Test Code M4.4 AND M4.5)
e. RET (Test Code M4.7)
f. BRAF V600E
g. NTRK
h. KRAS
i. HER2
Q2. Of the patients that were tested for each biomarker, how many patients tested positive?
a. MET (Test Code M4.3)
b. ALK (Test Code M4.11)
c. ROS1 (Test Code M4.6)
d. EGFR (Test Code M4.4 AND M4.5)
e. RET (Test Code M4.7)
f. BRAF V600E
g. NTRK
h. KRAS
i. HER2
Q3. Which NHS Trusts do you provide the genomic service for? i.e. Are you able to advise which trusts you carry out biomarker testing for as part of the NHS England Genomic Laboratory Hub network?
